Summary
The paper contains data on the presence of heparin inhibitor in erythrocytes of man, rabbits and dogs. The presence of heparin inhibitor in the erythrocytes was judged by the effect of the water erythrocytic hemolyzate on the tolerance of the plasma to heparin and coagulation time of the heparinized deprothrombinized plasma, with the thrombin in excess. It was established that the plasma tolerance to heparin rises when erythrocyte hemolyzate is added to the former. The coagulation ability of heparinized deprothrombinized plasma (caused by the thrombin action) rises in the presence of erythrocytic hemolyzate. The above phenomena are explained by the presence of heparin inhibitor in erythrocytes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literature Cited
V. P. Baluda, Byull. Eksptl. Biol. i Med., 44, No. 9, 7–9 (1957). Original Russian pagination. See C. B. Translation.
G. Cappeletti, Arch. Med. interna, 1957, v. 9, p. 35–57.
W. Connor, Carter J., Proc. Soc. Exper. Biol. a Med., 1958, v. 97, p. 38–43.
J. Georgatsos, C. Hussey, A. Quick, Am. J. Physiol., 1955, v. 181, p. 30–34.
P. Meneghini, Minerva med., 1956, v. 1, p. 2013–2023.
L. Pocora, M. Fusco, Riforma med., 1953, N. 3, p. 69–72.
Poller, Angiology, 1954, v. 5, S. 21–26.
A. Quick, C. Hussey, J. Lab. a. Clin. Med., 1955, v. 46, p. 940.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baluda, V.P., Gorbunova, N.A. The presence of a heparin inhibitor in the red blood cells. Bull Exp Biol Med 47, 700–703 (1959). https://doi.org/10.1007/BF00781224
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00781224